Aspirin versus clopidogrel beyond 1 month after percutaneous coronary intervention in high bleeding risk patients with or without acute coronary syndrome: a subgroup analysis from the STOPDAPT-3 trial.

Ishikawa T, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ikari Y, Kurita T, Kaitani K, Sugimoto A, Ogata N, Ikuta A, Hashimoto K, Ishibashi Y, Masuda K, Miyabe T, Ono K, Kimura T

Open source

DOI: 10.1007/s12928-026-01266-2
Published: 2026 Jul
Container: Cardiovascular intervention and therapeutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12928-026-01266-2,
  title = {Aspirin versus clopidogrel beyond 1 month after percutaneous coronary intervention in high bleeding risk patients with or without acute coronary syndrome: a subgroup analysis from the STOPDAPT-3 trial.},
  author = {Ishikawa T and Natsuaki M and Watanabe H and Morimoto T and Yamamoto K and Obayashi Y and Nishikawa R and Kimura T and Ando K and Suwa S and Isawa T and Takenaka H and Ikari Y and Kurita T and Kaitani K and Sugimoto A and Ogata N and Ikuta A and Hashimoto K and Ishibashi Y and Masuda K and Miyabe T and Ono K and Kimura T},
  year = {2026},
  journal = {Cardiovascular intervention and therapeutics},
  doi = {10.1007/s12928-026-01266-2},
  url = {https://doi.org/10.1007/s12928-026-01266-2}
}

RIS

TY  - JOUR
TI  - Aspirin versus clopidogrel beyond 1 month after percutaneous coronary intervention in high bleeding risk patients with or without acute coronary syndrome: a subgroup analysis from the STOPDAPT-3 trial.
AU  - Ishikawa T
AU  - Natsuaki M
AU  - Watanabe H
AU  - Morimoto T
AU  - Yamamoto K
AU  - Obayashi Y
AU  - Nishikawa R
AU  - Kimura T
AU  - Ando K
AU  - Suwa S
AU  - Isawa T
AU  - Takenaka H
AU  - Ikari Y
AU  - Kurita T
AU  - Kaitani K
AU  - Sugimoto A
AU  - Ogata N
AU  - Ikuta A
AU  - Hashimoto K
AU  - Ishibashi Y
AU  - Masuda K
AU  - Miyabe T
AU  - Ono K
AU  - Kimura T
PY  - 2026
JO  - Cardiovascular intervention and therapeutics
DO  - 10.1007/s12928-026-01266-2
UR  - https://doi.org/10.1007/s12928-026-01266-2
ER  -

APA

T, I., M, N., H, W., T, M., K, Y., Y, O., R, N., T, K., K, A., S, S., T, I., H, T., Y, I., T, K., K, K., A, S., N, O., A, I., K, H., Y, I., K, M., T, M., K, O., & T, K. (2026). Aspirin versus clopidogrel beyond 1 month after percutaneous coronary intervention in high bleeding risk patients with or without acute coronary syndrome: a subgroup analysis from the STOPDAPT-3 trial.. Cardiovascular intervention and therapeutics. https://doi.org/10.1007/s12928-026-01266-2

Source records

pubmed · retrieved 2026-09-26T22:07:32.356Z